Home Tags Superluminal Medicines

Superluminal Medicines

Superluminal Medicines, Inc., “The Membrane Company” using generative biology, chemistry, and machine learning approaches to revolutionize the speed and accuracy of how medicines are created, today announced the closing of a $120 million Series A funding round.

[Funding News] Superluminal Medicines Secures $120 Million in Series A Funding

Team SR -
© Copyright startuprise 2024 All Rights Reserved.
Exit mobile version